Upon analyzing TCGA-ovarian cancer dataset via the Gene Set Enrichment Analysis (GSEA) approach, we found a remarkable overlap between high expression profile of FAM46A and cisplatin resistance gene signatures (Figure 2(a)), suggesting that FAM46A might be involved in regulation of ovarian cancer cisplatin resistance. This evidence concerns the gene TENT5A and ovarian carcinoma.